MoneyWorks4Me

Windlas Biotech - Quaterly Results

11 Feb 2025 Evaluate
A fair growth of 20.22% in the revenue at Rs. 1950.19 millions was reported in the December 2024 quarter as compared to Rs. 1622.13 millions during year-ago period.Net profit showed a marginal rise at Rs. 152.27 millions for the quarter ended December 2024, as compared to corresponding quarter of last year.Operating profit surged to 283.69 millions from the corresponding previous quarter of 235.01 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1950.19 1622.13 20.22 5571.73 4596.71 21.21 6309.56 5130.83 22.97
Other Income 37.31 31.64 17.92 127.05 90.28 40.73 134.68 99.65 35.15
PBIDT 283.69 235.01 20.71 812.72 651.95 24.66 915.70 702.07 30.43
Interest 14.60 3.05 378.69 30.55 8.27 269.41 11.03 7.86 40.33
PBDT 269.09 231.96 16.01 782.17 643.68 21.52 904.67 694.21 30.32
Depreciation 69.39 33.89 104.75 196.50 99.08 98.32 134.44 123.64 8.74
PBT 199.70 198.07 0.82 585.67 544.60 7.54 770.23 570.57 34.99
TAX 47.43 47.09 0.72 142.03 132.65 7.07 188.79 144.13 30.99
Deferred Tax 8.20 2.39 243.10 5.36 4.42 21.27 15.35 0.63 2336.51
PAT 152.27 150.98 0.85 443.64 411.95 7.69 581.44 426.44 36.35
Equity 104.50 103.99 0.49 104.50 103.99 0.49 103.99 104.63 -0.61
PBIDTM(%) 14.55 14.49 0.41 14.59 14.18 2.84 14.51 13.68 6.06
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..